Y6S-13390-29566
2 vaccinations
3 coded responses
10 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 773 / TX
- Registered
- 2021-03-13
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-08
Dose 1 — Moderna
-
2021-03-13
Registered in v-safe
-
2021-03-13
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-14
-
2021-03-29
Survey response — day 21, dose 1MedDRA: Migraine — Feeling: Good · Be unable to do your normal daily activitiesFree text: Migraine headaches lasting 1 or more daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-05
-
2021-04-07
Dose 2 — Moderna
- 2021-04-15
- 2021-05-04
- 2021-05-05
-
2021-05-19
Survey response — day 42, dose 2MedDRA: Upper respiratory tract infection — Feeling: Poor · Be unable to workFree text: Upper respiratory infectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-07
-
2022-04-07
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Contracted covidMedDRA releases: 2024-11 · check-in free text available
-
2022-04-07
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-04-12
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Moderna | |
| 2 | 2021-04-07 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-07 | Successful 2022-04-12 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 6 — day 21, dose 1
Symptoms: Migraine headaches lasting 1 or more days
Release 8 — day 42, dose 2
Symptoms: Upper respiratory infection
Release 11 — 12 months, dose 2
Symptoms: Contracted covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Upper respiratory tract infection | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release